A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
Fuente:
arXiv
Saved in:
| Main Authors: | Li, Yuhan, Zhang, Yiding, Mi, Gu, Lin, Ji |
|---|---|
| Format: | Preprint |
| Published: |
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)
by: Lee, Kyong Ju, et al.
Published: (2025)
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)
by: Chen, Yuxuan, et al.
Published: (2026)
Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)
by: Hall, Andrew, et al.
Published: (2025)
A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)
by: Gu, Xuemin, et al.
Published: (2026)
DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
by: Yang, Cheng-Han, et al.
Published: (2024)
by: Yang, Cheng-Han, et al.
Published: (2024)
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)
by: Komaki, Moka, et al.
Published: (2025)
Decision Making in Drug Development via Inference on Power
by: Johnson, Geoffrey S
Published: (2020)
by: Johnson, Geoffrey S
Published: (2020)
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)
by: Zhu, Di, et al.
Published: (2026)
MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)
by: Lyu, Jiaying, et al.
Published: (2020)
Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
by: Yamada, Kana, et al.
Published: (2026)
by: Yamada, Kana, et al.
Published: (2026)
On Assessing Overall Survival (OS) in Oncology Studies
by: Hsu, Jason C.
Published: (2025)
by: Hsu, Jason C.
Published: (2025)
Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)
by: Kelter, Riko
Published: (2026)
Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
by: Ballerini, Veronica, et al.
Published: (2023)
by: Ballerini, Veronica, et al.
Published: (2023)
CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
by: Zhang, Fanni, et al.
Published: (2025)
by: Zhang, Fanni, et al.
Published: (2025)
Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
by: Amevor, Robert, et al.
Published: (2026)
by: Amevor, Robert, et al.
Published: (2026)
Pharmacometrics-Enabled DOse OPtimization (PEDOOP) for Seamless Phase I-II Trials in Oncology
by: Yuan, Shijie, et al.
Published: (2023)
by: Yuan, Shijie, et al.
Published: (2023)
Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025)
by: Zhang, Jiangshan, et al.
Published: (2025)
Robust Emax Model Fitting: Addressing Nonignorable Missing Binary Outcome in Dose-Response Analysis
by: Zhang, Jiangshan, et al.
Published: (2024)
by: Zhang, Jiangshan, et al.
Published: (2024)
HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
by: Shi, Junming, et al.
Published: (2024)
by: Shi, Junming, et al.
Published: (2024)
Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)
by: Sunami, Hisato, et al.
Published: (2024)
Nonparametric Bayesian Multi-Treatment Mixture Cure Survival Model with Application in Pediatric Oncology
by: Chang, Peter, et al.
Published: (2025)
by: Chang, Peter, et al.
Published: (2025)
Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
by: Maity, Arnab Kumar, et al.
Published: (2025)
by: Maity, Arnab Kumar, et al.
Published: (2025)
Distribution-Free Selection of Low-Risk Oncology Patients for Survival Beyond a Time Horizon
by: Sesia, Matteo, et al.
Published: (2025)
by: Sesia, Matteo, et al.
Published: (2025)
DROP: Distributionally Robust Optimization for Multi-task Learning in Graphical Models
by: Shen, Canruo, et al.
Published: (2026)
by: Shen, Canruo, et al.
Published: (2026)
Feasible Dose-Response Curves for Continuous Treatments Under Positivity Violations
by: Bao, Han, et al.
Published: (2025)
by: Bao, Han, et al.
Published: (2025)
Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
by: Silva, Rebecca B., et al.
Published: (2025)
by: Silva, Rebecca B., et al.
Published: (2025)
Efficient and Robust Block Designs for Order-of-Addition Experiments
by: Lin, Chang-Yun
Published: (2025)
by: Lin, Chang-Yun
Published: (2025)
Investigating the performance of the Phase II Hotelling T2 chart when monitoring multivariate time series observations
by: Nadi, Adel Ahmadi, et al.
Published: (2025)
by: Nadi, Adel Ahmadi, et al.
Published: (2025)
Shifting the Paradigm: Estimating Heterogeneous Treatment Effects in the Development of Walkable Cities Design
by: Zhu, Jie, et al.
Published: (2024)
by: Zhu, Jie, et al.
Published: (2024)
Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)
by: Kelter, Riko
Published: (2026)
Design-based nested instrumental variable analysis
by: Chen, Zhe, et al.
Published: (2025)
by: Chen, Zhe, et al.
Published: (2025)
Sequential Kalman filter for fast online changepoint detection in longitudinal health records
by: Li, Hanmo, et al.
Published: (2023)
by: Li, Hanmo, et al.
Published: (2023)
Powerful Foldover Designs
by: Stallrich, Jonathan W., et al.
Published: (2025)
by: Stallrich, Jonathan W., et al.
Published: (2025)
Sliced Elastic Distance for Evaluating Amplitude and Phase Differences in Precipitation Models
by: Garrett, Robert C., et al.
Published: (2023)
by: Garrett, Robert C., et al.
Published: (2023)
Regularized Fingerprinting in Detection and Attribution of Climate Change with Weight Matrix Optimizing the Efficiency in Scaling Factor Estimation
by: Li, Yan, et al.
Published: (2020)
by: Li, Yan, et al.
Published: (2020)
A Fully Bayesian Approach for Comprehensive Mapping of Magnitude and Phase Brain Activation in Complex-Valued fMRI Data
by: Wang, Zhengxin, et al.
Published: (2024)
by: Wang, Zhengxin, et al.
Published: (2024)
AgroDesign: A Design-Aware Statistical Inference Framework for Agricultural Experiments in Python
by: Gul, Aqib
Published: (2026)
by: Gul, Aqib
Published: (2026)
Addressing Phase Discrepancies in Functional Data: A Bayesian Approach for Accurate Alignment and Smoothing
by: Gardella, Jacopo, et al.
Published: (2025)
by: Gardella, Jacopo, et al.
Published: (2025)
A Universal Framework for Factorial Matched Observational Studies with General Treatment Types: Design, Analysis, and Applications
by: Zhu, Jianan, et al.
Published: (2025)
by: Zhu, Jianan, et al.
Published: (2025)
Rank-based methods for estimating landmark win probability in longitudinal randomized controlled trials with missing data
by: Zou, Guangyong, et al.
Published: (2026)
by: Zou, Guangyong, et al.
Published: (2026)
Similar Items
-
Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025) -
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026) -
Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025) -
A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026) -
DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
by: Yang, Cheng-Han, et al.
Published: (2024)